Papers - YONEYAMA TAKAHIRO
-
Comparison of efficacy and medical costs between upfront docetaxel and abiraterone treatments of metastatic hormone-sensitive prostate cancer patients in real-world practice: a multicenter retrospective study.
Ozaki K, Hatakeyama S, Narita S, Hata K, Yanagisawa T, Tanaka T, Togashi K, Hamaya T, Okamoto T, Yamamoto H, Yoneyama Ta, Hashimoto Y, Kimura T, Habuchi T, Ohyama C
World J Urol 2022.12
-
Associations of impaired grip strength and gait function with the severity of erectile dysfunction in men undergoing dialysis: a cross-sectional study．
Fujita N, Hatakeyama S, Momota M, Tobisawa Y, Yoneyama To, Okamoto T, Yamamoto H, Yoneyama Ta, Hashimoto Y, Yoshikawa K, Ohyama C
Aging Male 25 ( 1 ) 1 - 7 2022.11
-
Effects of apalutamide dose reduction on skin-related adverse events in patients with advanced prostate cancer: A multicenter retrospective study．
Oishi T, Hatakeyama S, Tabata R, Fujimori D, Kawashima Y, Tanaka R, Ishii N, Miura H, Tanaka T, Okamoto T, Yamamoto H, Yoneyama Ta, Hashimoto Y, Sato S, Ohyama C
Prostate 2022.10
-
Relationships of low-grade systemic inflammation and nutritional status with erectile dysfunction severity in men on dialysis．
Fujita N, Hatakeyama S, Momota M, Hamaya T, Tobisawa Y, Yoneyama To, Okamoto T, Yamamoto H, Yoneyama Ta, Hashimoto Y, Yoshikawa K, Ohyama C
Andrology 2022.8
-
Risk score-based substratification improves surveillance costs after transurethral resection of bladder tumor in patients with primary high-risk non-muscle-invasive bladder cancer．
Fujita N, Hatakeyama S, Momota M, Tobisawa Y, Yoneyama To, Yamamoto H, Ito H, Yoneyama Ta, Hashimoto Y, Yoshikawa K, Ohyama C
Sci Rep. 2022.8
-
TMEM2 expression is downregulated as bladder cancer invades the muscle layer．
Yoneyama MS, Yoneyama To, Tobisawa Y, Yamamoto H, Hatakeyama S, Yoneyama Ta, Hashimoto Y, Suzuki T, Ohyama C
Biochem Biophys Res Commun 2022.7
-
Effect of active anticancer therapy on serologic response to SARS-CoV-2 BNT162b2 vaccine in patients with urothelial and renal cell carcinoma．
10. Togashi K, Hatakeyama S, Yoneyama To, Hamaya T, Narita T, Fujita N, Iwamura H, Okamoto T, Yamamoto H, Yoneyama Ta, Hashimoto Y, Ohyama C
Int J Urol 2022.7
-
Impact of body size on skin-related adverse events in advanced prostate cancer treated with apalutamide: A multicenter retrospective study．
8. Sasaki D, Hatakeyama S, Tanaka T, Okamoto T, Yoneyama Ta, Ohyama C
Int J Urol 2022.7
-
Significance of pelvic lymph node dissection during radical prostatectomy in high-risk prostate cancer patients receiving neoadjuvant chemohormonal therapy．
Iwamura H, Hatakeyama S, Narita T, Ozaki Y, Konishi S, Horiguchi H, Kodama H, Kojima Y, Fujita N, Okamoto T, Tobisawa Y, Yoneyama To, Yamamoto H, Yoneyama Ta, Hashimoto Y, Ohyama C
Sci Rep. 2022.6
-
Association between Aortic Calcification Burden and the Severity of Erectile Dysfunction in Men Undergoing Dialysis: A Cross-Sectional Study．World J Mens Health.
Fujita N, Hatakeyama S, Momota M, Tobisawa Y, Yoneyama To, Okamoto T, Yamamoto H, Yoneyama Ta, Hashimoto Y, Yoshikawa K, Ohyama C
World J Mens Health 2022.5
-
Seroprevalence of SARS-CoV-2 spike IgG antibodies after the second BNT162b2 mRNA vaccine in Japanese kidney transplant recipients．
11. Hamaya T, Hatakeyama S, Yoneyama To, Tobisawa Y, Kodama H, Fujita T, Murakami R, Fujita N, Okamoto T, Yamamoto H, Yoneyama Ta, Hashimoto Y, Saitoh H, Narumi S, Tomita H, Ohyama C
Sci Rep 2022.4
-
Single immediate instillation of chemotherapy is associated with decreased recurrence and progression in patients with high-risk non-muscle-invasive bladder cancer who receive adjuvant induction bacillus Calmette-Guérin therapy．
Fujita N, Hatakeyama S, Momota M, Narita T, Tobisawa Y, Yoneyama To, Yamamoto H, Ito H, Yoneyama Ta, Hashimoto Y, Yoshikawa K, Ohyama C
Int J Urol 2022.2
-
Effect of upfront combination therapy on the overall survival of patients with metastatic castration-sensitive prostate cancer: A multicenter retrospective study．
4. Tanaka T, Hatakeyama S, Noro D, Togashi K, Yoneyama Ta, Ohyama C
Int J Urol 2022.2
-
Proportion of patients eligible for adjuvant immunotherapy in nonmetastatic clear-cell renal cell carcinoma treated with radical or partial nephrectomy．
Tanaka R, Hatakeyama S, Miura H, Hamaya T, Yoneyama Ta, Ohyama C
Int J Urol 2022.1
-
Characteristics of α2,3-sialyl N-glycosylated PSA as a biomarker for clinically significant prostate cancer in men with elevated PSA level．
24. Yoneyama T, Yamamoto H, Sutoh Yoneyama M, Tobisawa Y, Hatakeyama S, Narita T, Kodama H, Momota M, Ito H, Narita S, Tsushima F, Mitsuzuka K, Yoneyama T, Hashimoto Y, Duivenvoorden W, Pinthus JH, Kakeda S, Ito A, Tsuchiya N, Habuchi T, Ohyama C
Clin Cancer Res. 27 ( 22 ) 6164 - 6173 2021.11
-
Utility of total cell-free DNA levels for surgical damage evaluation in patients with urological surgeries．
28. Konishi S, Narita T, Hatakeyama S, Yoneyama T, Yoneyama MS, Tobisawa Y, Noro D, Sato T, Togashi K, Okamoto T, Yamamoto H, Yoneyama T, Hashimoto Y, Ohyama C
Sci Rep. 11 ( 1 ) 2021.11
-
Oncologic and patient-reported outcomes after robot-assisted radical prostatectomy in men aged ≥75 years
Kyo Togashi , Shingo Hatakeyama , Teppei Okamoto , Yuta Kojima , Hiromichi Iwamura , Naoki Fujita , Takuma Narita , Itsuto Hamano , Tomoko Hamaya , Tohru Yoneyama , Hayato Yamamoto , Takahiro Yoneyama , Yasuhiro Hashimoto , Chikara Ohyama
Urol Oncol 39 ( 10 ) 2021.10
-
Comparison of pembrolizumab with conventional chemotherapy after first-line platinum-based chemotherapy for advanced urothelial carcinoma in real-world practice: A multicenter retrospective study．
16. Narita T, Hatakeyama S, Numakura K, Kobayashi M, Muto Y, Saito M, Narita S, Tanaka T, Noro D, Tokui N, Yoneyama T, Hashimoto Y, Habuchi T, Ohyama
Int J Url 28 ( 9 ) 899 - 905 2021.9
-
Prognostic significance of the Ki67 index and programmed death-ligand 1 expression after radical cystectomy in patients with muscle-invasive bladder cancer.
Hirotaka Horiguchi, Shingo Hatakeyama, Tohru Yoneyama, Mihoko Sutoh Yoneyama, Toshikazu Tanaka, Naoki Fujita, Teppei Okamoto, Hayato Yamamoto, Takahiro Yoneyama, Tadashi Yoshizawa, Yasuhiro Hashimoto, Toshiaki Kawaguchi, Chikara Ohyama
Urologic oncology 39 ( 4 ) 238.e9 - 238.e17 2021.4
-
Altered gut microbiome associated with overactive bladder and daily urinary urgency.
Teppei Okamoto, Shingo Hatakeyama, Atsushi Imai, Hayato Yamamoto, Tohru Yoneyama, Kazuyuki Mori, Takahiro Yoneyama, Yasuhiro Hashimoto, Shigeyuki Nakaji, Chikara Ohyama
World journal of urology 39 ( 3 ) 847 - 853 2021.3
-
Overactive bladder and sleep disturbance have a significant effect on indoor falls: Results from the community health survey in Japan.
Sakae Konishi, Shingo Hatakeyama, Atsushi Imai, Mika Kumagai, Kazutaka Okita, Kyo Togashi, Tomoko Hamaya, Itsuto Hamano, Teppei Okamoto, Hiromichi Iwamura, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
Lower urinary tract symptoms 13 ( 1 ) 56 - 63 2021.1
-
A Longitudinal Study of Bidirectional Relationships between Sleep Disorder and Frequency of Nocturia: Results from the Iwaki Health Promotion Project.
Sakae Konishi, Shingo Hatakeyama, Atsushi Imai, Mika Kumagai, Teppei Okamoto, Kazutaka Okita, Itsuto Hamano, Takuma Narita, Yuta Kojima, Hiromichi Iwamura, Hayato Yamamoto, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
Urologia internationalis 105 ( 3-4 ) 232 - 239 2021
-
非失禁型腸管利用 新膀胱造設術
米山高弘 畠山真吾 橋本安弘 大山 力
泌尿器科 13 ( 6 ) 2021
-
RARC と回腸を利用した尿路変向術
米山高弘＊ 富樫 赳 堀口裕貴 小玉寛健 成田拓磨 岩村大径 小島由太 岡本哲平 山本勇人 畠山真吾 橋本安弘 大山 力
( 34 ) 2021
-
Frailty is significantly associated with the type of urinary diversion in patients with muscle-invasive bladder cancer.
Kazutaka Okita, Shingo Hatakeyama, Masaki Momota, et al
International journal of urology : official journal of the Japanese Urological Association 27 ( 8 ) 649 - 654 2020.5
-
Outcome of ABO Blood Type-Incompatible Living-Related Donor Kidney Transplantation Under a Contemporary Immunosuppression Strategy in Japan.
Itsuto Hamano, Shingo Hatakeyama, Takeshi Fujita, et al
Transplantation proceedings 52 ( 6 ) 1700 - 1704 2020.5
-
Geriatric 8 screening of frailty in patients with prostate cancer.
Masaki Momota, Shingo Hatakeyama, Osamu Soma, Toshikazu Tanaka, Itsuto Hamano, Naoki Fujita, Teppei Okamoto, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Kazuaki Yoshikawa, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
International journal of urology : official journal of the Japanese Urological Association 27 ( 8 ) 642 - 648 2020.5
-
Impact of substratification on predicting oncological outcomes in patients with primary high-risk non-muscle-invasive bladder cancer who underwent transurethral resection of bladder tumor.
Naoki Fujita, Shingo Hatakeyama, Masaki Momota, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Hiroyuki Ito, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Chikara Ohyama
Urologic oncology 38 ( 10 ) 795.e9 - 795.e17 2020.4
-
Safety and efficacy of intensive instillation of low-dose pirarubicin vs. bacillus Calmette-Guérin in patients with high-risk non-muscle-invasive bladder cancer.
Naoki Fujita, Shingo Hatakeyama, et al
Urologic oncology 38 ( 8 ) 684.e17 - 684.e24 2020.4
-
Influence of pretreatment quality of life on prognosis in patients with urothelial carcinoma.
Sappaya Suppanuntaroek, Shingo Hatakeyama, Naoki Fujita, Yuka Kubota, Yuichiro Suzuki, Teppei Okamoto, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Kazuyuki Mori, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
International journal of clinical oncology 25 ( 2 ) 362 - 369 2020.2
-
ハイリスク前立腺癌に対する術前内分泌化学療法後のロボット支援前立腺全摘術（RARP）の治療成績
米山高弘，他
Japanese Society of Endourology 33 325 - 329 2020
-
The Impact of Glycosylation of Osteopontin on Urinary Stone Formation.
Go Anan, Tohru Yoneyama, Daisuke Noro, Yuki Tobisawa, Shingo Hatakeyama, Mihoko Sutoh Yoneyama, Hayato Yamamoto, Atsushi Imai, Hiromichi Iwamura, Yuki Kohada, Jotaro Mikami, Jun Ito, Yasuhiro Kaiho, Takahiro Yoneyama, Yasuhiro Hashimoto, Makoto Sato, Chikara Ohyama
International journal of molecular sciences 21 ( 1 ) 2019.12
-
The Relationship Between Gait Function and Erectile Dysfunction: Results from a Community-Based Cross-Sectional Study in Japan.
Teppei Okamoto, Shingo Hatakeyama, Atsushi Imai, Sakae Konishi, Kazutaka Okita, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Kazuyuki Mori, Takahiro Yoneyama, Yasuhiro Hashimoto, Shigeyuki Nakaji, Chikara Ohyama
The journal of sexual medicine 16 ( 12 ) 1922 - 1929 2019.12
-
Serum N-glycan profiling is a potential biomarker for castration-resistant prostate cancer.
Teppei Matsumoto, Shingo Hatakeyama, Tohru Yoneyama, Yuki Tobisawa, Yusuke Ishibashi, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Hiroyuki Ito, Shin-Ichiro Nishimura, Chikara Ohyama
Scientific reports 9 ( 1 ) 16761 - 16761 2019.11
-
Bilateral scrotal mass mimicking testicular cancer: An unusual presentation of sarcoidosis.
Sakae Konishi, Shingo Hatakeyama, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
International journal of urology : official journal of the Japanese Urological Association 26 ( 11 ) 1079 - 1081 2019.11
-
Impact of nadir PSA level and time to nadir during initial androgen deprivation therapy on prognosis in patients with metastatic castration-resistant prostate cancer.
Itsuto Hamano, Shingo Hatakeyama, Shintaro Narita, Masahiro Takahashi, Toshihiko Sakurai, Sadafumi Kawamura, Senji Hoshi, Masanori Ishida, Toshiaki Kawaguchi, Shigeto Ishidoya, Jiro Shimoda, Hiromi Sato, Koji Mitsuzuka, Tatsuo Tochigi, Norihiko Tsuchiya, Yoichi Arai, Tomonori Habuchi, Chikara Ohyama
World journal of urology 37 ( 11 ) 2365 - 2373 2019.11
-
Validation of the IMDC Prognostic Model in Patients With Metastatic Renal-Cell Carcinoma Treated With First-Line Axitinib: A Multicenter Retrospective Study.
Sakae Konishi, Shingo Hatakeyama, Kazuyuki Numakura, Shintaro Narita, Takamitsu Inoue, Mitsuru Saito, Noriko Tokui, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Satoshi Narita, Toshiaki Kawaguchi, Tomonori Habuchi, Chikara Ohyama
Clinical genitourinary cancer 17 ( 5 ) e1080 - e1089 2019.10
-
Multicenter prospective study validating the efficacy of a quantitative assessment tool for frailty in patients with urological cancers.
Osamu Soma, Shingo Hatakeyama, Teppei Okamoto, Naoki Fujita, Itsuto Hamano, Toshikazu Tanaka, Masaki Momota, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Hisao Saitoh, Shigeyuki Nakaji, Tadashi Suzuki, Chikara Ohyama
Medical oncology (Northwood, London, England) 36 ( 10 ) 88 - 88 2019.9
-
Impact of Disagreement Between Two Risk Group Models on Prognosis in Patients With Metastatic Renal-Cell Carcinoma.
Kazutaka Okita, Shingo Hatakeyama, Toshiaki Tanaka, Yoshinori Ikehata, Toshikazu Tanaka, Naoki Fujita, Yusuke Ishibashi, Hayato Yamamoto, Takahiro Yoneyama, Yasuhiro Hashimoto, Kazuaki Yoshikawa, Toshiaki Kawaguchi, Naoya Masumori, Hiroshi Kitamura, Chikara Ohyama
Clinical genitourinary cancer 17 ( 3 ) e440 - e446 2019.7
-
Robot-assisted radical cystectomy in a patient with muscle-invasive bladder cancer following radiotherapy for prostate cancer.
Yuka Kubota, Shingo Hatakeyama, Takuya Hashimoto, Naoki Fujita, Teppei Okamoto, Yuichiro Suzuki, Hayato Yamamoto, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama
IJU case reports 2 ( 4 ) 236 - 239 2019.7
-
Impact of distance between donor and recipient hospitals on cadaveric kidney transplantation outcomes.
Itsuto Hamano, Shingo Hatakeyama, Hayato Yamamoto, Takeshi Fujita, Reiichi Murakami, Michiko Shimada, Atsushi Imai, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Shunji Narumi, Hisao Saitoh, Tadashi Suzuki, Hirofumi Tomita, Chikara Ohyama
Clinical and experimental nephrology 23 ( 6 ) 807 - 813 2019.6
-
Evaluating the effects of switching from dutasteride to tadalafil in benign prostatic hyperplasia patients with lower urinary tract symptoms: A randomized, open-label, multicenter study.
Teppei Matsumoto, Shingo Hatakeyama, et al
International journal of urology : official journal of the Japanese Urological Association 2019.1
-
Robotic cross-folded U-configuration intracorporeal ileal neobladder for muscle-invasive bladder cancer: Initial experience and functional outcomes.
Takuya Koie, Chikara Ohyama, et al
The international journal of medical robotics + computer assisted surgery : MRCAS 14 ( 6 ) e1955 - e1955 2018.12
-
Postoperative weight loss followed by radical cystectomy predicts poor prognosis in patients with muscle-invasive bladder cancer.
Kazutaka Okita, Shingo Hatakeyama, Naoki Fujita, Sakae Konishi, Hayato Yamamoto, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Hiroyuki Ito, Kazuaki Yoshikawa, Takuya Koie, Chikara Ohyama
Medical oncology (Northwood, London, England) 36 ( 1 ) 7 - 7 2018.11
-
Comparison of axitinib and sunitinib as first-line therapies for metastatic renal cell carcinoma: a real-world multicenter analysis.
Sakae Konishi, Shingo Hatakeyama, et al
Medical oncology (Northwood, London, England) 36 ( 1 ) 6 - 6 2018.11
-
Differences in semen characteristics between patients with testicular cancer and other malignancies using various cut-off values.
Itsuto Hamano, Shingo Hatakeyama, et al
International journal of urology : official journal of the Japanese Urological Association 25 ( 9 ) 817 - 824 2018.9
-
Relationship between oxidative stress and lower urinary tract symptoms: results from a community health survey in Japan.
Teppei Matsumoto, Shingo Hatakeyama, et al
BJU international 2018.9
-
Sleep Disturbance Has a Higher Impact on General and Mental Quality of Life Reduction than Nocturia: Results from the Community Health Survey in Japan.
Koichi Kido, Shingo Hatakeyama, et al
European urology focus 2018.5
-
Risk-stratified surveillance protocol improves cost-effectiveness after radical nephroureterectomy in patients with upper tract urothelial carcinoma.
Masaki Momota, Shingo Hatakeyama,et al
Oncotarget 9 ( 33 ) 23047 - 23057 2018.5
-
Clinical implication of a quantitative frailty assessment tool for prognosis in patients with urological cancers.
Osamu Soma, Shingo Hatakeyama, et al
Oncotarget 9 ( 25 ) 17396 - 17405 2018.4
-
Partial Cystectomy of Paraganglioma of the Urinary Bladder Before Living Kidney Transplantation: Case Report.
K Kido, T Yoneyama, et al
Transplantation proceedings 50 ( 3 ) 898 - 901 2018.4
-
Overall survival of high-risk prostate cancer patients who received neoadjuvant chemohormonal therapy followed by radical prostatectomy at a single institution.
Fujita N, Yoneyama T, et al
Int J Clin Oncol 22 ( 6 ) 1087 - 1093 2017.12
-
Presurgical axitinib therapy increases fibrotic reactions within tumor thrombus in renal cell carcinoma with thrombus extending to the inferior vena cava
Tanaka Y, Yoneyama T, et al
international journal of clinical oncology 2017.7
-
Contrast media enhancement reduction predicts tumor response to presurgical molecular-targeting therapy in patients with advanced renal cell carcinoma.
Hosogoe S, Yoneyama T,et al
Oncotarget 8 ( 30 ) 49749 - 49756 2017.7
-
Preoperative chronic kidney disease predicts poor oncological outcomes after radical cystectomy in patients with muscle-invasive bladder cancer.
1. Hamano I, Yoneyama T,et al
Oncotarget 29 ( 8 ) 61404 - 61414 2017.5
-
Difference in toxicity reporting between patients and clinicians during systemic chemotherapy in patients with urothelial carcinoma.
Ken Fukushi, Takuma Narita, Shingo Hatakeyama, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama
International journal of urology : official journal of the Japanese Urological Association 2017.3
-
The feasibility and effectiveness of robot-assisted radical cystectomy after neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer.
Takuya Koie, Chikara Ohyama, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Tohru Yoneyama, Yuki Tobisawa, Atsushi Yamauchi, Toru Shimazui, Mikinobu Ohtani
Japanese journal of clinical oncology 47 ( 3 ) 252 - 256 2017.3
-
Efficacy of a neoadjuvant gonadotropin-releasing hormone antagonist plus low-dose estramustine phosphate in high-risk prostate cancer: a single-center study.
Kazuhisa Hagiwara, Takuya Koie, Chikara Ohyama, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Yuki Tobisawa, Tohru Yoneyama
International urology and nephrology 2017.2
-
Aortic calcification burden predicts deterioration of renal function after radical nephrectomy.
Ken Fukushi, Shingo Hatakeyama, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Osamu Soma, Teppei Matsumoto, Itsuto Hamano, Takuma Narita, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Yuriko Terayama, Tomihisa Funyu, Chikara Ohyama
BMC urology 17 ( 1 ) 13 - 13 2017.2
-
The utility of neoadjuvant gemcitabine plus carboplatin followed by immediate radical cystectomy in patients with muscle-invasive bladder cancer who are ineligible for cisplatin-based chemotherapy.
Hiromi Murasawa, Takuya Koie, Chikara Ohyama, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Ikuya Iwabuchi, Masaru Ogasawara, Toshiaki Kawaguchi
International journal of clinical oncology 22 ( 1 ) 159 - 165 2017.2
-
Solitary Fibrous Tumor of the Prostate Which Was Initially Misdiagnosed as Prostate Cancer.
Soma Osamu, Hiromi Murasawa, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama
Case reports in urology 2017 3594914 - 3594914 2017
-
Quality-of-life evaluation during platinum-based neoadjuvant chemotherapies for urothelial carcinoma.
Ken Fukushi, Takuma Narita, Shingo Hatakeyama, Hayato Yamamoto, Osamu Soma, Teppei Matsumoto, Yuki Tobisawa, Tohru Yoneyama, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama
International journal of clinical oncology 2016.12
-
Implication of aortic calcification on persistent hypertension after laparoscopic adrenalectomy in patients with primary aldosteronism.
Naoki Fujita, Shingo Hatakeyama, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Takeshi Nigawara, Chikara Ohyama
International journal of urology : official journal of the Japanese Urological Association 23 ( 5 ) 412 - 417 2016.5
-
Safety of heparin bridging therapy for transrectal ultrasound-guided prostate biopsy in patients requiring temporary discontinuation of antithrombotic agents.
Itsuto Hamano, Shingo Hatakeyama, Tohru Yoneyama, Yuki Tobisawa, Osamu Soma, Teppei Matsumoto, Hayato Yamamoto, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama
SpringerPlus 5 ( 1 ) 1917 - 1917 2016
-
Efficacy and Safety of Silodosin and Dutasteride Combination Therapy in Acute Urinary Retention due to Benign Prostatic Hyperplasia: A Single-Arm Prospective Study.
Kazuhisa Hagiwara, Takuya Koie, Hiromichi Iwamura, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
BioMed research international 2016 4975851 - 4975851 2016
-
Slow Gait Speed and Rapid Renal Function Decline Are Risk Factors for Postoperative Delirium after Urological Surgery.
Tendo Sato, Shingo Hatakeyama, Teppei Okamoto, Hayato Yamamoto, Shogo Hosogoe, Yuki Tobisawa, Tohru Yoneyama, Eiji Hashiba, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Kazuyoshi Hirota, Chikara Ohyama
PloS one 11 ( 5 ) e0153961 - e0153961 2016
-
Correction: Renal Function Outcomes and Risk Factors for Risk Factors for Stage 3B Chronic Kidney Disease after Urinary Diversion in Patients with Muscle Invasive Bladder Cancer.
Shingo Hatakeyama, Takuya Koie, Takuma Narita, Shogo Hosogoe, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
PloS one 11 ( 3 ) e0151742 - e0151742 2016
-
Renal Function Outcomes and Risk Factors for Stage 3B Chronic Kidney Disease after Urinary Diversion in Patients with Muscle Invasive Bladder Cancer [corrected].
Shingo Hatakeyama, Takuya Koie, Takuma Narita, Shogo Hosogoe, Hayato Yamamoto, Yuki Tobisawa, Tohru Yoneyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Chikara Ohyama
PloS one 11 ( 2 ) e0149544 - e0149544 2016
-
Eviprostat has an identical effect compared to pollen extract (Cernilton) in patients with chronic prostatitis/chronic pelvic pain syndrome: a randomized, prospective study.
Iwamura H, Koie T, Yoneyama T, et al
BMC Urol. 15 ( 120 ) 2015.12
-
Significance of preoperative butyrylcholinesterase as an independent predictor of biochemical recurrence-free survival in patients with prostate cancer treated with radical prostatectomy.
Koie T, Ohyama C, Hatakeyama S, Ima A, Yoneyama T, et al
Int J Clin Oncol. 2015.6
-
Feasibly of axitinib as first-line therapy for advanced or metastatic renal cell carcinoma: a single-institution experience in Japan.
Koie T, Ohyama C, Yoneyama T, et al
BMC Urol 15(1) ( 32 ) 2015.4
-
A solitary positive prostate cancer biopsy does not predict a unilateral lesion in radical prostatectomy specimens.
Takuya Koie, Koji Mitsuzuka, Shintaro Narita, Takahiro Yoneyama, Sadafumi Kawamura, Yasuhiro Kaiho, Norihiko Tsuchiya, Tatsuo Tochigi, Tomonori Habuchi, Yoichi Arai, Chikara Ohyama
Scandinavian journal of urology 49 ( 2 ) 103 - 107 2015.4
-
Carboplatin-based combination chemotherapy for elderly patients with advanced bladder cancer.
Takahiro Yoneyama, Yuki Tobisawa, Tohru Yoneyama, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama
International journal of clinical oncology 20 ( 2 ) 369 - 374 2015.4
-
Sequential chemotherapy using gemcitabine + carboplatin followed by gemcitabine + carboplatin + docetaxel for advanced upper-tract urothelial cancer.
Yoneyama T, Imai A, Hatakeyama S, et al
Int J Clin Oncol. 2015.3
-
Lymphovascular invasion is significantly associated with biochemical relapse after radical prostatectomy even in patients with pT2N0 negative resection margin.
K Mitsuzuka, S Narita, T Koie, Y Kaiho, N Tsuchiya, T Yoneyama, N Kakoi, S Kawamura, T Tochigi, C Ohyama, T Habuchi, Y Arai
Prostate cancer and prostatic diseases 18 ( 1 ) 25 - 30 2015.3
-
術前化学療法の現況 Cisplatin-unfit 症例および高齢者に対するNeoadjuvant therapy
米山 高弘
泌尿器外科 28 ( 3 ) 267 - 272 2015.3
-
Prostate-specific antigen density predicts extracapsular extension and increased risk of biochemical recurrence in patients with high-risk prostate cancer who underwent radical prostatectomy
2. Koie T, Mitsuzuka K, Yoneyama T, Narita S, Kawamura S, Kaiho Y, Tsuchiya N, Tochigi T, Habuchi T, Arai Y, Ohyama C, Yoneyama T, Tobisawa Y
Int J Clin Oncol 20 ( 1 ) 176 - 181 2015.2
-
Differences in the recurrence pattern after neoadjuvant chemotherapy compared to surgery alone in patients with muscle-invasive bladder cancer.
Takuya Koie, Chikara Ohyama, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Tohru Yoneyama, Yuki Tobisawa
Medical oncology (Northwood, London, England) 32 ( 1 ) 421 - 421 2015.1
-
Efficiency of pretreatment risk stratification systems for prostate cancer in a Japanese population treated with radical prostatectomy.
Takuya Koie, Koji Mitsuzuka, Shintaro Narita, Takahiro Yoneyama, Sadafumi Kawamura, Norihiko Tsuchiya, Tatsuo Tochigi, Tomonori Habuchi, Yoichi Arai, Chikara Ohyama
International journal of urology : official journal of the Japanese Urological Association 22 ( 1 ) 70 - 73 2015.1
-
[Leiomyosarcoma of the prostate treated with neoadjuvant intra-arterial chemotherapy and pelvic excenteration ; a case report].
Daisuke Noro, Takahiro Yoneyama, Kazuhisa Hagiwara, Kazuyuki Mori, Hayato Yamamoto, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama
Hinyokika kiyo. Acta urologica Japonica 60 ( 11 ) 579 - 582 2014.11
-
Serum tri- and tetra-antennary N-glycan is a potential predictive biomarker for castration-resistant prostate cancer.
Yusuke Ishibashi, Yuki Tobisawa, Shingo Hatakeyama, Tetsu Ohashi, Masakazu Tanaka, Shintaro Narita, Takuya Koie, Tomonori Habuchi, Shin-Ichiro Nishimura, Chikara Ohyama, Tohru Yoneyama
The Prostate 74 ( 15 ) 1521 - 1529 2014.11
-
Significance of preoperative butyrylcholinesterase as an independent predictor of survival in patients with muscle-invasive bladder cancer treated with radical cystectomy.
Takuya Koie, Chikara Ohyama, Hayato Yamamoto, Shingo Hatakeyama, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Masato Kitayam, Kazuyoshi Hirota
Urologic oncology 32 ( 6 ) 820 - 825 2014.8
-
Neoadjuvant gemcitabine and carboplatin followed by immediate cystectomy may be associated with a survival benefit in patients with clinical T2 bladder cancer.
Takuya Koie, Chikara Ohyama, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Tohru Yoneyama, Yuki Tobisawa
Medical oncology (Northwood, London, England) 31 ( 5 ) 949 - 949 2014.5
-
Both radical prostatectomy following treatment with neoadjuvant LHRH agonist and estramustine and radiotherapy following treatment with neoadjuvant hormonal therapy achieved favorable oncological outcome in high-risk prostate cancer: a propensity-score matching analysis.
3. Koie T, Ohyama C, Yamamoto H, Imai A, Hatakeyama S, Yoneyama T, Hashimoto Y, Yoneyama T, Tobisawa Y, Aoki M, Takai Y
World J Surg Oncol. 12 2014.4
-
Are pathological and oncological outcomes of elderly men treated with radical prostatectomy worse than those of younger men? Matched-pair analysis between patients aged <70 and ≥70 years.
5. Mitsuzuka K, Koie T, Narita S, Kaiho Y, Yoneyama T, Tsuchiya N, Kakoi N, Kawamura S, Tochigi T, Ohyama C, Habuchi T, Arai Y
Jpn J Clin Oncol. 44 ( 6 ) 587 - 592 2014.4
-
Post-transplant renal function and cardiovascular events are closely associated with the aortic calcification index in renal transplant recipients.
K Imanishi, S Hatakeyama, H Yamamoto, A Okamoto, A Imai, T Yoneyama, Y Hashimoto, T Koie, T Fujita, R Murakami, H Saitoh, T Funyu, S Narumi, C Ohyama
Transplantation proceedings 46 ( 2 ) 484 - 488 2014.3
-
A case of metastatic cancer with markedly elevated PSA level that was not detected by repeat prostate biopsy.
Hiromichi Iwamura, Shingo Hatakeyama, Yoshimi Tanaka, Toshikazu Tanaka, Noriko Tokui, Hayato Yamamoto, Atsushi Imai, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Kazuaki Yoshikawa, Chikara Ohyama
BMC research notes 7 64 - 64 2014.1
-
Neoadjuvant chemotherapy with gemcitabine plus carboplatin followed by immediate radical cystectomy for muscle-invasive bladder cancer.
Chikara Ohyama, Shingo Hatakeyama, Takahiro Yoneyama, Takuya Koie
International journal of urology : official journal of the Japanese Urological Association 21 ( 1 ) 3 - 4 2014.1
-
Surgery without Blood Transfusion for Giant Paraganglioma in a Jehovah's Witness Patient.
Takuya Narita, Itsuto Hamano, Ayumu Kusaka, Hiromi Murasawa, Noriko Tokui, Kengo Imanishi, Teppei Okamoto, Hayato Yamamoto, Atsushi Imai, Shingo Hatakeyama, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Chikara Ohyama, Kenichi Hakamada
Case reports in oncology 7 ( 1 ) 233 - 238 2014.1
-
Renal cell carcinoma detected by preoperative kidney transplant donor examination: a case report.
T Sato, Takahiro Yoneyama, K Hagiwara, T Narita, D Noro, T Tanaka, Y Tanaka, Y Tobisawa, Tohru Yoneyama, H Yamamoto, A Okamoto, A Imai, S Hatakeyama, Y Hashimoto, T Koie, C Ohyama
Transplantation proceedings 46 ( 2 ) 634 - 636 2014
-
Efficacies and safety of neoadjuvant gemcitabine plus carboplatin followed by immediate cystectomy in patients with muscle-invasive bladder cancer, including those unfit for cisplatin: a prospective single-arm study.
Takuya Koie, Chikara Ohyama, Yasuhiro Hashimoto, Shingo Hatakeyama, Hayato Yamamoto, Takahiro Yoneyama, Noritaka Kamimura
International journal of clinical oncology 18 ( 4 ) 724 - 730 2013.8
-
Prognosis of Elderly Japanese Patients Aged ≥80 Years Undergoing Hemodialysis．
Hatakeyama S，et al
The Scientific World Journal 2013.7
-
慢性腎不全
米山高弘，盛 和行，大山 力
臨床泌尿器科 67 ( 4 ) 203 - 206 2013.4
-
急性腎不全
2. 米山高弘，盛 和行，大山 力
臨床泌尿器科 67 ( 4 ) 207 - 208 2013.4
-
[Testicular tumor arising in intra-abdominal testis which was not detected at prior orchidopexy : a case report].
Hiromichi Iwamura, Shingo Hatakeyama, Ken Fukushi, Tendo Sato, Yuta Kojima, Hiromi Murasawa, Hirofumi Ishimura, Takahiro Yoneyama, Takuya Koie, Noritaka Kamimura, Satoko Morobashi, Hiroshi Kijima, Chikara Ohyama
Hinyokika kiyo. Acta urologica Japonica 59 ( 3 ) 189 - 193 2013.3
-
Blood group antigen-targeting peptide suppresses anti-blood group antibody binding to antigen in renal glomerular capillaries after ABO-incompatible blood reperfusion.
Tohru Yoneyama, Shingo Hatakeyama, Yuki Tobisawa, Hayato Yamamoto, Kengo Imanishi, Teppei Okamoto, Noriko Tokui, Naoki Sugiyama, Yuichiro Suzuki, Shigemasa Kudo, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Noritaka Kamimura, Michiko N Fukuda, Chikara Ohyama
Transplantation 95 ( 3 ) 418 - 425 2013.2
-
当科における生体腎移植ドナー腎採取術の検討
米山高弘，他
腎移植・血管外科 24 ( 1 ) 9 - 13 2012.12
-
Safety and effectiveness of neoadjuvant luteinizing hormone-releasing hormone agonist plus low-dose estramustine phosphate in high-risk prostate cancer: a prospective single-arm study.
T Koie, C Ohyama, H Yamamoto, S Hatakeyama, T Yoneyama, Y Hashimoto, N Kamimura
Prostate cancer and prostatic diseases 15 ( 4 ) 397 - 401 2012.12
-
Minimum incision endoscopic radical cystectomy in patients with malignant tumors of the urinary bladder: clinical and oncological outcomes at a single institution.
T Koie, C Ohyama, H Yamamoto, S Hatakeyama, S Kudoh, T Yoneyama, Y Hashimoto, N Kamimura
European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology 38 ( 11 ) 1101 - 1105 2012.11
-
[Metastatic renal tumor from oral floor cancer: a case report].
Yusuke Ishibashi, Shingo Hatakeyama, Teppei Okamoto, Yuichiro Suzuki, Shigemasa Kudo, Takahiro Yoneyama, Takuya Koie, Noritaka Kamimura, Hirotaka Sakaki, Wataru Kobayashi, Hiroto Kimura, Chikara Ohyama
Hinyokika kiyo. Acta urologica Japonica 58 ( 11 ) 609 - 612 2012.11
-
Sarcoidosis of the ureter.
Yasuhiro Hashimoto, Shigemasa Kudoh, Hayato Yamamoto, Shingo Hatakeyama, Takahiro Yoneyama, Takuya Koie, Noritaka Kamimura, Chikara Ohyama
Urology 79 ( 6 ) e81 - e82 2012.6
-
Biochemical outcome of small-volume or insignificant prostatecancer treated with radical prostatectomy in Japanese population. （共著）
Yasuhiro Hashimoto, Akiko Okamoto, Atsushi Imai, Tohru Yoneyama, Shingo Hatakeyama, Takahiro Yoneyama, Takuya Koie, Noritaka Kaminura, Chikara Ohyama
International journal of Clinical Oncology 17 ( 2 ) 119 - 123 2012.4
-
Skin perfusion pressure is a prognostic factor in hemodialysis patients.
Shingo Hatakeyama, Masaaki Saito, Kumiko Ishigaki, Hayato Yamamoto, Akiko Okamoto, Yusuke Ishibashi, Hiromi Murasawa, Kengo Imanishi, Noriko Tokui, Teppei Okamoto, Yuichiro Suzuki, Naoki Sugiyama, Atsushi Imai, Shigemasa Kudo, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Noritaka Kaminura, Hisao Saitoh, Tomihisa Funyu, Chikara Ohyama
International journal of nephrology 2012 385274 - 385274 2012.4
-
Effect of an Oral Adsorbent, AST-120, on Dialysis Initiation and Survival in Patients with Chronic Kidney Disease.
Shingo Hatakeyama, Hayato Yamamoto, Akiko Okamoto, Kengo Imanishi, Noriko Tokui, Teppei Okamoto, Yuichiro Suzuki, Naoki Sugiyama, Atsushi Imai, Shigemasa Kudo, Takahiro Yoneyama, Yasuhiro Hashimoto, Takuya Koie, Noritaka Kamimura, Hisao Saitoh, Tomihisa Funyu, Chikara Ohyama
International Journal of Nephrology 2012.1
-
A Switch From Conventional Twice-Daily Tacrolimus to Once-Daily Extended-Release Tacrolimus in Stable Kidney Transplant Recipients．（共著）
S. Hatakeyama, T. Fujita, T. Yoneyama, T. Yoneyama, T. Koie, Y. Hashimoto, H. Saitoh, T. Funyu, S. Narumi, and C. Ohyama
Transplantation Proceedings 44 ( 1 ) 121 - 123 2012.1
-
Requirement for FBP17 in invadopodia formation by invasive bladder tumor cells.（共著）
Yamamoto H, Sutoh M, Hatakeyama S, Hashimoto Y, Yoneyama T, Koie T, Saitoh H, Yamaya K, Funyu T, Nakamura T, Ohyama C, Tsuboi S
The Journal of Urology 185 ( 5 ) 1930 - 1938 2011.5
-
Core 2 N-acetylglucosaminyltransferase-1 (C2GnT-1) expression induces aggressive potential of testicular germ cell tumor.（共著）
Hatakeyama S, Kyan A, Yamamoto H, Okamoto A, Sugiyama N, Suzuki Y, Yoneyama T, Hashimoto Y, Koie T, Yamada S, Saito H, Arai Y, Fukuda M, Ohyama C
International Journal of Cancer 127 ( 5 ) 1052 - 1059 2010.9
-
Risk factors for erectile dysfunction in healthy Japanese man．（共著）
Atsushi Imai, et al.
International Journal of Andrology 33 ( 4 ) 569 - 573 2010.8
-
Invadopodia formation by bladder tumor cells. （共著）
Sutoh Mihoko, Hashimoto Yasuhiro,Yoneyama Takahiro, Yamamoto Hayato, et al.l.
Oncology Research 19 ( 2 ) 85 - 92 2010.2
-
腎周囲脂肪織に発症した多発性炎症性偽腫瘍の1例
山本勇人 他
泌尿器科紀要 2009.12
-
腎Solitary fibrous tumorの1例
米山高弘 他
泌尿器科紀要 2009.8
-
Uterus-, Fallopian Tube-, Ovary-, and Vagina-Sparing Cystectomy Followed by U-shaped Ileal Neobladder Construction for Female Bladder Cancer Patients: Oncological and Functional Outcomes.
Koie T, et al
Urology 2009.5
-
An aggressive course of Xp11 translocation renal cell carcinoma in a 28-year-old man.
Koie T, et al
international journal of urology 2009.3
-
Protein profiling of post-prostatic massage urine specimens by surface-enhanced laser desorption/ionization time-of-flight mass spectrometry to discriminate between prostate cancer and benign lesions.
Okamoto A, at al
ONCOLOGY REPORTS 2009.3
-
An aggressive course of Xp11 translocation renal cell carcinoma in a 28-year-old man. （共著）
Koie T, Yoneyama T, Hashimoto Y, Kamimura N, Kusumi T, Kijima H, Ohyama C
International Journal of Urology 16 ( 3 ) 333 - 335 2009.3
-
Frequency of postoperative inguinal hernia after endoscope-assisted mini-laparotomy and conventional retropubic radical prostatectomies.I
Koie T, et al
International Journal of Urology 2008.3
-
Low-Dose Instillation Therapy with Bacille Calmette-Guérin Tokyo 172 Strain After Transurethral Resection: Historical Cohort Study.
Yoneyama T, et al
Urology 2008.2
-
Positive expressions of N-acetylglucosaminyltransferase-V (GnT-V) and beta1-6 branching N-linked oligosaccharides in human testicular germ cells diminish during malignant transformation and progression.
Kyan A, et al
International Journal of Oncology. 2008.1
-
尿路として利用された腸管の発癌性について
大山力、他
Urology View 2007.3
-
Experience and functional outcome of modified ileal neobladder in 95 patients
Takuya Koie, et al
International Journal of UROLOGY 2006.9
-
当科におけるミニマム創内視鏡下根治的前立腺全摘除術 ー手術手技と治療成績ー
古家琢也、他
泌尿器外科 2006.6
-
一側の尿管閉塞を伴う融合腎
工藤茂将、他
臨床泌尿器科 2004.11
-
保存的加療が奏効しなかった尿管結石による腎周囲膿瘍を合併した膿腎症の１例
米山高弘、他
泌尿器外科 2004.7
-
ＣＥＡ高値を示した右腎盂尿管癌の１例
今井篤、米山高弘、他
泌尿器外科 2004.6
-
腹腔鏡補助下小切開前立腺全摘除術 ー手術方法および初期１０例の臨床的検討
古家琢也、米山高弘、他
泌尿器外科 2004.5
-
異所性褐色細胞腫の１例
今井篤、他
泌尿器外科 2003.5
-
成人男性の膀胱後部に発生した類皮嚢胞の１例
神村典孝、古家琢也、米山高弘、他
泌尿器科紀要 2003.3
-
腫瘍摘出後２年１ヶ月後に同部位に再発した腎周囲脂肪肉腫の１例
古家琢也、他
西日本泌尿器科 2003.3
-
両側副腎悪性リンパ腫
米山高弘、他
臨床泌尿器科 2003.1